Fundraising Fox

Healthtech Investors & VC Firms in China

120 firms in this list, with a median first check of $1M. 6 of them lead rounds. Generated from verified public data and updated continuously.

Source Code Capital
BeijingSeed–Growth
7 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
35 people
Advent International
BostonSeries A–Late Stage$1.1B
36 people
Celesta Capital
San MateoSeed–Late Stage
7 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
11 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
UpHonest Capital
Palo AltoPre-Seed–Series B
15 people
Mitsui Global Investment
Menlo ParkSeed–Late Stage$500K – $10M
7 people
K3 Ventures
Seed–Series B
8 people
HongShan
Hong KongPre-Seed–Late Stage$100K – $50M
11 people
UOB Venture Management
SingaporeSeed–Growth$10M – $50M
8 people
IDG Capital
Hong KongPre-Seed–Late Stage$1M – $100M
11 people
Legend Capital
Hong KongPre-Seed–Growth$2M – $10M
8 people
Shenzhen Capital Group
ShenzhenSeed–Growth$1M – $3.5M
3 people
GSR Ventures
BeijingPre-Seed–Series B$100K – $20M
6 people
Signia Venture Partners
Menlo ParkSeed–Series A$500K – $2M
5 people
SBVA
SeoulSeed–Series B$1M – $2.5M
11 people
Vertex Ventures HC
San FranciscoSeed–Growth$500K – $10M
5 people
SBCVC
TortolaSeed–Late Stage
6 people
Impact Fund Denmark
Copenhagen KSeed–Late Stage$2.2M – $70.2M
11 people
YuanBio Venture Capital
SuzhouSeed–Growth
7 people
China Growth Capital
BeijingPre-Seed–Series A
3 people
Swedfund International AB
StockholmSeries A–Series B$3M – $10M
9 people
EDB Investments
Seed–Series B
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.